The media have reported news of a potential treatment for multiple sclerosis which uses technology similar to two of the Covid-19 vaccines. We’ve taken a closer look to find out more about the research behind the headlines.
The news story is based on a study published in the journal Science. German researchers injected messenger RNA (mRNA) into mice with an MS-like condition. The mRNA had been amended to instruct certain cells to produce substances similar to myelin, the fatty protein which acts as insulation for nerve cells. In MS, the immune system mistakenly attacks and destroys the myelin. The aim of this study was to induce the immune system to tolerate myelin, rather than attack it.
The researchers found that when the mRNA was injected into mice with MS-like disease, the mice developed less severe disease than would normally occur.
The research uses similar technology to two of the Covid-19 vaccines (Pfizer/BioNTech and Moderna) but used in a different way. Instead of using a vaccine to prime the immune system to recognise and fight off an infection, this approach uses the vaccine to teach the immune system to tolerate (or ignore) myelin.
So far, this approach has only been tested in mouse models of MS. The results are encouraging but translating a treatment from the MS-like condition in mice is not straightforward. Further research will need to study whether it is effective and safe in humans. However, the technology shows potential, and we will be keeping a close watch for any further developments.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
Krienke C, Kolb L, Diken E, et al.
Science 2021; 371(6525): 145-153.
Read the summary
Ozanimod (Zeposia) approved for relapsing remitting MS in Scotland
8 Feb 2021 - 00:00
The MS Trust is delighted that ozanimod (Zeposia) has been approved in Scotland for people with active relapsing remitting multiple sclerosis.
Exercise is good for your brain
3 Feb 2021 - 00:00
There is more to exercise than physical fitness. This review looks at recent research which shows how exercise has a direct beneficial effect on brain repair processes.
Covid-19 vaccines and MS: Part two
29 Jan 2021 - 00:00
Following our last interview on the subject of the Covid-19 vaccine and people with MS, we received a lot of follow up questions. To answer some of these, we spoke once again to Professor Alasdair Coles, Consultant Neurologist at Addenbrooke’s hospital.
My search for MS support while studying for a PhD
4 Mar 2021 - 00:00
Laura is studying a PhD in Cancer Genomics and was diagnosed with MS in September 2020 following multiple hospital admissions. Here, Laura talks about how this affected her mental health and what more could be done to support other students going through the same thing.
MS, my mental health and a university degree
4 Mar 2021 - 00:00
Scarlet talks about how she learnt to manage her MS and mental health alongside the stresses of completing a university degree.
Receiving an MS diagnosis during my gender transition
22 Feb 2021 - 00:00
Chris shares his experience of being diagnosed with MS at the same time as starting hormone treatment and a surgical gender transition.